Capital Resource Alliance, Inc. (OTCMKTS:CRRA) announced it has entered into a letter of intent to acquire and to execute a reverse merger with Nate’s Pancakes, Inc., an Indiana corporation in which Nate’s Pancakes will became a wholly owned subsidiary of the Company (the “Merger”). WB Partners had previously announced this transaction via a press release. Capital Resource Alliance Inc (OTCMKTS:CRRA) on last trading day company shares ended up $0.0430.
Dendreon Corporation (Nasdaq:DNDN) reported results for the first quarter ended March 31, 2014. Net product revenue for the quarter was $68.8 million compared to $67.6 million in the first quarter of 2013. Net loss in the first quarter of 2014 was $36.4 million, or $0.24 per share, compared to a net loss of $72.0 million, or $0.48 per share for the same period in 2013. As of March 31, 2014, Dendreon had approximately $170 million in cash, cash equivalents, and short-term and long-term investments. Dendreon Corporation (NASDAQ:DNDN) shares fell -3.24% in last trading session and ended the day on $2.09. Gross Margin is 41.40% and its return on assets is -54.60%. Dendreon Corporation (NASDAQ:DNDN) quarterly performance is -27.43%.
Bankrate, Inc. (NYSE:RATE) announced the acquisition of Caring, Inc., a privately held, San Mateo California-based company and the owner of Caring.com, a leading senior care resource for those seeking information and support as they care for aging family members and loved ones. Caring.com provides assisted living and eldercare content, online support groups, and a comprehensive Senior Care Directory for the United States. Caring generates revenue primarily through referral fees from senior housing communities, as well as subscription and display revenue. The purchase price of $54 million in cash is subject to adjustments, and the Caring team will join Bankrate, Inc. Bankrate Inc (NYSE:RATE) shares moved up 0.41% in last trading session and was closed at $14.83, while trading in range of $14.76 – $15.30. Bankrate Inc (NYSE:RATE) year to date (YTD) performance is -17.34%.
Northwest Biotherapeutics, Inc (NASDAQ:NWBO)’s shares jumped 2.19% to $6.07. The company on May 15 provided an initial patient case study, showing signs of tumor necrosis (tumor death) and initial tumor regression, from the Company’s ongoing DCVax-Direct trial for all types of inoperable solid tumors. The Company plans to announce further case study information prior to the annual ASCO conference, while it continues collecting data from the trial. Although the trial is still at an early stage, with many of the patients only part way through the treatment regimen, the Company also plans to provide overall information about the data to date by the time of the ASCO conference.Northwest Biotherapeutics, Inc (NASDAQ:NWBO) ended the last trading day at $6.00. Company weekly volatility is calculated as 9.21% and price to cash ratio as 18.17. Northwest Biotherapeutics, Inc (NASDAQ:NWBO) showed a positive weekly performance of 21.46%.
HollyFrontier Corp (NYSE:HFC) SVP George John Damiris unloaded 14,507 shares of the company’s stock in a transaction dated Tuesday, May 13th. The shares were sold at an average price of $50.49, for a total value of $732,458.43. Following the sale, the senior vice president now directly owns 28,037 shares of the company’s stock, valued at approximately $1,415,588. HollyFrontier Corp (NYSE:HFC) net profit margin is 3.60% and weekly performance is -1.02%. On last trading day company shares ended up $49.55. Analysts mean target price for the company is $53.59. HollyFrontier Corp (NYSE:HFC) distance from 50-day simple moving average (SMA50) is 0.34%.